市場調査レポート

商品コード

1566193

ペン型注入器の市場規模、シェア、成長分析、タイプ別、療法別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Injection Pen Market Size, Share, Growth Analysis, By Type, By Therapy, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年10月03日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

ペン型注入器の世界市場規模は2022年に450億米ドルと評価され、予測期間（2024-2031年）のCAGRは7.93%で、2023年の485億7,000万米ドルから2031年には894億3,000万米ドルに成長する見通しです。

世界のペン型注入器市場は、慢性疾患の増加、患者中心のケアへの注力、ヘルスケアテクノロジーの進歩などの要因が重なり、大幅な成長を遂げています。この変革的な市場は、製品タイプ、治療タイプ、最終用途に分類され、使い捨てペン型注入器と再利用可能ペン型注入器の両方が重要な役割を担っていることを強調しています。使い捨てペン型注入器は、その費用対効果と利便性が評価され、特に資源が限られた環境や新興経済国で採用が進んでいます。特にGLP-1ペンのような使いやすいインスリン送達システムの需要を牽引しています。これらのデバイスは、競合情勢が激化する中、主要市場プレーヤーにとって重要な焦点となっています。さらに、世界のペン型注入器市場は多様な地域力学を示し、北米はヘルスケア業界のリーダーが集中し、多くのメーカーがこの地域に進出していることから、主導権を握っています。米国は、ペン型注入器の生産と技術革新の極めて重要な拠点として際立っており、市場動向を形成し、効率的な注射ソリューションに対する需要の高まりに対応する役割をさらに確固たるものにしています。進化する医療ニーズと技術進歩の組み合わせにより、ペン型注入器市場は当面拡大し続けるものと思われます。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Novo Nordisk A/S（Denmark）
Eli Lilly And Company（US）
Sanofi（France）
Ypsomed Holding AG（Switzerland）
Becton, Dickinson and Company（US）
Merck KGaA（Germany）
AstraZeneca（UK）
Owen Mumford（UK）
Sun Pharmaceutical Industries Ltd（India）
Pfizer Inc.（US）
Biocon（India）
Lupin（India）
Wockhardt Ltd.（India）
Medtronic（US）
Gerresheimer AG（Germany）
Shaily Engineering Plastics Ltd.（India）
SHL Medical AG（Switzerland）
Emperra GmbH E-Health Technologies（Germany）
Nemera France SAS（France）
Jiangsu Delfu Medical Device Co., Ltd.（China）
Solteam Medical（China）
Stevanato Group（Italy）
Wanhai Medical Instruments Co., Ltd.（China）

Product Code: SQMIG35A2646

Global Injection Pen Market size was valued at USD 45 billion in 2022 and is poised to grow from USD 48.57 billion in 2023 to USD 89.43 billion by 2031, growing at a CAGR of 7.93% during the forecast period (2024-2031).

The global injection pen market is witnessing substantial growth due to a convergence of factors such as increasing chronic disease prevalence, a focus on patient-centric care, and advancements in healthcare technology. This transformative market, categorized into product type, therapy type, and end use, highlights the significant roles of both disposable and reusable injection pens. Disposable injection pens, praised for their cost-effectiveness and convenience, have seen heightened adoption, particularly in resource-limited settings and emerging economies. Within the therapy-specific segment, insulin pens dominate, influenced by the rising global diabetes rate and the growing elderly population that drives demand for user-friendly insulin delivery systems, notably GLP-1 pens. These devices represent a significant focus for key market players amid a competitive landscape. Moreover, the global injection pen market exhibits varied regional dynamics, with North America leading the charge, thanks to its concentration of healthcare industry leaders and numerous manufacturers expanding their footprint within the region. The United States stands out as a pivotal hub for injection pen production and innovation, further solidifying its role in shaping market trends and addressing the growing demand for efficient injection solutions. With a combination of evolving medical needs and technological progress, the injection pen market is positioned for continued expansion in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Injection Pen market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Injection Pen Market Segmental Analysis

Global Injection Pen Market is segmented by Type, Therapy, End User, and region. Based on Type, the market is segmented into Disposable Injection Pens, and Reusable Injection Pens. Based on Therapy, the market is segmented into Diabetes, Growth Hormone Therapy, Osteoporosis, Fertility, Obesity, and Other Therapies. Based on End User, the market is segmented into Home Care Settings, Hospitals & Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Injection Pen Market

The integration of advanced technologies into drug delivery systems serves as a significant market driver for the global Injection Pen market. Innovations such as electronic dose memory, Bluetooth connectivity for data tracking, and precision dose delivery mechanisms have revolutionized patient experiences and treatment outcomes. These enhancements make injection pens more user-friendly and accessible, fostering greater adoption among patients, caregivers, and healthcare professionals alike. By improving ease of use and ensuring accurate dosing, these technological advancements not only elevate patient satisfaction but also bolster adherence to prescribed therapies, stimulating market growth and establishing injection pens as essential tools in modern healthcare management.

Restraints in the Global Injection Pen Market

One significant market restraint impacting the global injection pen market is the affordability and accessibility challenges in developing regions. Patients in these areas often grapple with the high costs associated with injection pens and related therapies, which can pose a substantial financial burden, especially in regions with lower economic development. Additionally, limited healthcare infrastructure restricts both the availability and distribution of these advanced drug delivery devices, further hindering access for patients who rely on them for chronic disease management. Consequently, these barriers have a pronounced effect on market growth and the overall adoption of injection pens in these underserved populations.

Market Trends of the Global Injection Pen Market

The global injection pen market is witnessing a significant trend towards personalized and connected solutions that enhance patient engagement and medication adherence. As healthcare increasingly embraces digitalization, the incorporation of advanced connectivity features in injection pens allows for real-time monitoring of patient compliance and tracking of administered doses. This transformation is shifting traditional injection pens into smart devices that facilitate remote management of patients, offering insights into their medication routines. Consequently, pharma companies and manufacturers are investing in research and development to create innovative injection pens that leverage data sharing and technology to improve patient outcomes and streamline healthcare delivery.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Technology Analysis
Supply Chain Analysis
Trade Analysis
Value Chain Analysis
Regulatory Landscape
Patent Analysis
Pricing Analysis
Customer & Buying Criteria Analysis
Case Study Analysis

Injection Pen Market by Type

Market Overview
Disposable Injection Pens
Reusable Injection Pens

Injection Pen Market by Therapy

Market Overview
Diabetes
- Insulin
- Glucagon-Like Peptide-1
Growth Hormone Therapy
Osteoporosis
Fertility
Obesity
Other Therapies

Injection Pen Market by End User

Market Overview
Home Care Settings
Hospitals & Clinics

Injection Pen Market Size by Region

Market Overview
North America
- US
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Novo Nordisk A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly And Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocon (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lupin (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wockhardt Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shaily Engineering Plastics Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SHL Medical AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emperra GmbH E-Health Technologies (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nemera France SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiangsu Delfu Medical Device Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solteam Medical (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stevanato Group (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wanhai Medical Instruments Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

ペン型注入器の市場規模、シェア、成長分析、タイプ別、療法別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Injection Pen Market Size, Share, Growth Analysis, By Type, By Therapy, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

ペン型注入器市場：タイプ別

ペン型注入器市場：療法別

ペン型注入器市場：エンドユーザー別

ペン型注入器市場規模：地域別